Clinical trial
Comparison of Atomoxetine and Placebo in Children With…
NCT00191906 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00191906 |
|---|---|
| Title | Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD) |
| Official title | A Randomized, Double-Blind, Crossover Comparison of Atomoxetine and Placebo in Child Outpatients With Attention-Deficit/Hyperactivity Disorder, Reading Disorder, or Comorbid Attention-Deficit/Hyperactivity Disorder and Reading Disorder. |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Attention Deficit Hyperactivity Disorder, Reading Disorder |
| Intervention type | Drug |
| Interventions | Atomoxetine Hydrochloride, placebo |
| Enrollment | 121 |
| Start date | Apr 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Sep 19, 2005 |
| Last update posted | May 25, 2010 |
| Countries | Belgium, Netherlands |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: